Skip to content

The effects of foot drop stimulator controlled by a tilt sensor combined with integrated volitional control electrical stimulation on gait performance in stroke patients

The effects of foot drop stimulator controlled by a tilt sensor combined with integrated volitional control electrical stimulation on gait performance in stroke patients - The effects of foot drop stimulator controlled combined with integrated volitional control electrical stimulation in stroke patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000025482
Enrollment
60
Registered
2017-01-04
Start date
2017-01-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Foot drop stimulator controlled combined with integrated volitional control electrical stimulation in addition to usual rehabilitation program Integrated volitional control electrical stimulation in a

Sponsors

Shiroishi Kyoritsu Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Consent to participate in the study 2) First-time stroke with a duration of less than 6 months from the onset of stroke 3) The ability to walk without support for at least 30-meters 4) The score of SIAS foot-pat test is 1 or more. 5) Capability of communicating and understanding instructions

Exclusion criteria

Exclusion criteria: 1) Contraindications for electrical stimulation 2) Severe sensory deficits 3) Neurological condition unrelated to stroke hemiparesis

Design outcomes

Primary

MeasureTime frame
Root mean squares of trunk acceleration during walking

Secondary

MeasureTime frame
fugl-meyer assessment (the lower extremity), stroke impairment assessment set (foot-pat test), modified ashworth scale

Countries

Japan

Contacts

Public ContactTsubasa Mitsutake

Shiroishi Kyoritsu Hospital Department of Rehabilitation

mitutuba1012@gmail.com0952-84-6060

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026